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Abstract
Background: Hematopoietic stem cell transplantation (HSCT) is the treatment of choice for young Hurler patients.
Despite halting of neurocognitive decline and improvement of life expectancy, the beneficial effect on the skeletal
system is limited. As orthopedic complications are one of the most disabling factors following HSCT, this points to
the need for new treatment strategies. The study summarizes musculoskeletal manifestations in 19 transplanted
Hurler patients.
Methods: Data were obtained retrospectively. Patients’ charts for physical examinations of the joint range of
motion (JROM) of shoulders, elbows, hips and knees were reviewed. Radiographic evaluations of thorax, spine,
pelvis and hands were performed. MRI scans of the craniocervical junction were analyzed to determine odontoid
hypoplasia and the prevalence of craniocervical stenosis.
Results: Nineteen Hurler patients (10 females, 9 males) with an average age of 8.1 years (range 2.5–23.8) at the
latest follow-up, who underwent allogenic HSCT between 1991 and 2012, were assessed after an average follow-up
period of 6.4 years (range 0.7–22.5). Seventeen patients achieved long-term engraftment, two developed graft
failures. The majority of patients showed a steady state or improvements in the mobility of knees (31 %/63 %), hips
(47 %/40 %) and elbows (56 %/38 %). However, shoulder abduction was impaired in ¾ of patients and showed the
highest rate of progression (31 %). In patients with graft failure, progressive restrictions in JROM were noted.
Assessments of the craniocervical junction by MRI showed stable or improved diameters in 67 % of patients.
Correction or stabilization of odontoid hypoplasia was found in 64 %. However thoracolumbar kyphosis, scoliosis,
hip dysplasia and genua valga were progressive despite HSCT. At the last follow up, 47 % of patients were partially
wheelchair dependent, 10 % wheelchair bound and 25 % regularly experienced pain in the spine, hips and lower
extremities due to orthopedic problems.
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Conclusion: Joint mobility, odontoid hypoplasia and craniocervical stenosis might stabilize or even improve in
Hurler patients following HSCT. However, despite the beneficial effects on some musculoskeletal manifestations,
skeletal complications are frequently observed and the overall burden of orthopedic disease is significant. Frequent
multi-disciplinary follow-up in a specialized center are essential. Novel therapeutic approaches (e.g.
anti-inflammatory drugs) are needed to improve musculoskeletal outcomes.
Keywords: Mucopolysaccharidosis type I, Hurler syndrome, Musculoskeletal manifestations, Craniocervical stenosis,
Odontoid hypoplasia, Thoracolumbar kyphosis, Hip dysplasia, Dysostosis multiplex
Background
Mucopolysaccharidosis (MPS) type I is an autosomal re-
cessive inherited metabolic disorder caused by a defi-
ciency of lysosomal α-iduronidase (IDUA, EC 3.2.1.76).
Consequently, the glycosaminoglycans (GAGs) heparan-
and dermatan-sulfate accumulate within the lysosomes
causing cellular dysfunction [1, 2]. The incidence of
MPS I in Germany has been estimated as 0.69 cases per
100,000 births [3]. Clinical severity and progression of
the disease vary significantly in affected patients. Based
on the clinical appearance three different subtypes of
MPS I are classified: the classical severe phenotype re-
ferred to as Hurler syndrome (MPS I-H), the less severe
Hurler-Scheie syndrome (MPS I-H/S) and the attenuated
form - Scheie syndrome (MPS I-S) [1, 2, 4]. Clinical
symptoms of Hurler syndrome include the characteris-
tically coarse facial features, corneal clouding, hearing
impairment, cardiac involvement, obstructive and re-
strictive pulmonary disease and hepatosplenomegaly.
With increasing age patients also show progressive
neurological decline. Musculoskeletal involvement is
common in all subtypes of MPS I. Skeletal abnormal-
ities include: a short stature, degenerative joint dis-
ease and a skeletal dysplasia referred to as dysostosis
multiplex [5, 6].
The pathophysiology of the bone disease is still not
well understood. Disordered growth plate chondrocyte
organization and trabecular architecture were observed
in several animal models of different MPS subtypes [7].
As shown in studies in MPS I mice, accumulation of
GAGs could lead to inactivation of the major osteo-
clastic protease cathepsin K, which in turn may result in
reduction in cartilage degradation and contribute to the
bone pathology observed in MPS [8]. The progressive ar-
thropathy is assumed to be mediated by GAG accumula-
tion, resulting in increased cytokine and chemokine
recruitment (e.g. TNF-alpha, IL-1-beta) and leads to in-
creased apoptosis of chondrocytes, synovial hyperplasia
and inflammatory joint destruction - despite the lack of
clinical inflammation signs [9, 10].
Craniocervical stenosis (CCS) with consecutive spinal
cord compression and neurological symptoms such as
paraplegia are known features of severe MPS I-H and
can lead to significant disability [11]. Narrowing of the
cervical spinal canal at the craniocervical junction (CCJ)
is presumed to originate from bony stenosis, peri-
odontoid soft tissue masses, hypertrophy of the anterior
and posterior longitudinal ligaments and dural thicken-
ing [11–13]. Furthermore atlanto-axial instability due to
odontoid hypoplasia can lead to spinal cord compression
and myelopathy [11, 14, 15]. In addition, MPS I patients
have a high risk of developing a carpal tunnel syndrome
(CTS) due to bone dysplasia as well as thickening of syno-
via and ligaments [16–19]. Early recognition and treat-
ment of CTS are important to protect severe limitations
in hand acquirements. Diagnosis of CTS can be difficult
because of the absence of characteristic clinical symptoms
such as nocturnal pain, numbness or tingling [19, 20].
Therapeutic options in MPS I are hematopoietic stem
cell transplantation (HSCT) and, since 2003, disease-
specific enzyme replacement therapy (ERT) with recom-
binant α-iduronidase [21]. HSCT is the treatment of
choice in Hurler patients ≤2.0 years of age with a devel-
opmental quotient (DQ) of >70 [5] and has altered the
natural history of MPS I-H dramatically, leading to clin-
ical improvements and the halting of neurocognitive de-
cline. Skeletal manifestations, on the other hand, have
remained progressive [11, 22–24]. Due to the available
therapies, life expectancy and survival have improved
significantly in patients with MPS I, accentuating the
need for new concepts to treat the orthopedic manifesta-
tions. However, there is a lack of knowledge concerning
the impact of the available treatments on the skeletal
system [25, 26].
The purpose of this study was a longitudinal evaluation
of muculoskeletal manifestations in 19 Hurler patients fol-
lowing hematopoietic stem cells transplantation.
Methods
All patients attended the MPS outpatient clinic at the
University Medical Center Hamburg-Eppendorf and
were monitored and examined between 1991 and 2014.
Nineteen patients (9 male, 10 female) with an average
age of 8.1 years (range 2.5–23.8 years) at the latest
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follow-up met the inclusion criteria: diagnosis of MPS I
confirmed by enzyme activity determination and/or gen-
etic testing, Hurler phenotype, hematopoietic stem cell
transplantation (HSCT) and a minimum of two ortho-
pedic evaluations.
All available data before HSCT, as well as changes of
musculoskeletal manifestations following HSCT, were col-
lected retrospectively by reviewing patient charts, radio-
graphs of thorax, spine, pelvis and hands as well as
magnetic resonance imaging (MRI) scans of the craniocer-
vical junction (CCJ). Furthermore, any surgical interven-
tions for musculoskeletal disease were analyzed. HSCT
was carried out at an average age of 1.6 years (1.1–
2.2 years), follow-up after HSCT ranged between 0.7 and
22.5 years. All data were anonymized before analysis.
Joint mobility
Physical examinations of joint range of motion (JROM)
of shoulders, elbows, hips and knees recorded in the pa-
tient charts were reviewed. The following movements
were analyzed based on the clinical relevance: shoulder
abduction, elbow extension, hip extension and knee ex-
tension. Joint contractures were categorized as mild,
moderate and severe. Restriction of shoulder abduction
was classified as mild (deficit ≤40°), moderate (deficit of
50–80°) or severe (deficit ≥90°). Flexion joint contrac-
tures of elbows, hips and knees were classified as mild
(5–15°), moderate (≥15°) or severe (≥25°). The course of
joint disease was analyzed a minimum of six months
after HSCT.
Odontoid hypoplasia and craniocervical stenosis
Odontoid hypoplasia and the prevalence of craniocervi-
cal stenosis (CCS) were analyzed by MRI. To evaluate
odontoid hypoplasia an odontoid process/odontoid body
ratio was calculated as described previously [27]. A ratio
below 2 was termed hypoplasia. The measurements were
done on 3–4 mm sagittal T2-weighted images using a
1.5 Tesla MRI scanner. In addition, axial and coronal
T2- or T1-weighted sequences were used for identifica-
tion of the odontoid, if available. To quantify the CCS
the smallest anterior-to-posterior diameter of the CCJ
(vertebrae C1-C3) was measured. An anterior-to-
posterior diameter of less than 14 mm was defined as a
cervical stenosis [28]. Patient charts were reviewed for
surgical decompression of the CCS or stabilization in
case of atlanto-axial instability.
Thoracolumbar kyphosis and scoliosis
Kyphotic angle and degree of scoliosis were determined
by radiograph of the thoracolumbar spine. The measure-
ments were performed by standardized technique from
end vertebra to end vertebra and were specified by Cobb
angle assessments in the sagittal plane [29].
Hip dysplasia
Radiographic evaluations of the hips were performed on
anterior-posterior pelvic radiographs with hips in neutral
rotation and a supine position. Hip dysplasia was quanti-
fied by the acetabular index (AI). According to the
method of Toennies and Brunken [30] acetabular dys-
plasia was specified by an AI ≥2 standard deviations
(SD). Furthermore, the Reimers’ head migration index
(MI) was used to classify the hip joint stability into nor-
mal (<25 %), subluxation (33–99 %) and dislocation
(100 %) [31]. The records of patients who underwent
surgical interventions were reviewed to identify the age
at intervention, as well as the type and number of
surgeries.
Further signs of dysostosis multiplex
Dysostosis multiplex is characterized by abnormalities of
skeletal features including thorax, spine, pelvis, limbs
and hands [1, 2, 5]. Any available radiographs were




Nine male and ten female Hurler patients with an
average age of 8.1 years (range 2.5–23.8 years) at the
latest follow-up fulfilled the inclusion criteria. Genetic
testing was available in 17 patients. In two patients
diagnosis was confirmed by enzymatic testing and the
clinical phenotype only. The study population is sum-
marized in Table 1.
Hematopoietic stem cell transplantation (HSCT) was
carried out at an average age of 1.6 years (1.1–2.2 years);
follow-up after HSCT ranged between 0.7 and 22.5 years
(average 6.4 years). Patients 3, 6 and 9 were transplanted
in other centers; all others received HSCT at the Stem
Cell Transplantation Unit at the University Medical
Center in Hamburg. Five patients received enzyme re-
placement therapy (ERT) prior to HSCT (patients 1, 2,
3, 6 and 9). Fourteen patients received HSCT from an
HLA-identical unrelated donor, while two patients were
transplanted from HLA-identical family donors (patients
18 and 19). Two patients (patients 5 and 11) were trans-
planted from HLA-mismatched unrelated donors and
patient 1 received HSCT from a haplo-identical family
donor. The most commonly used conditioning regime
(n = 9, 47 %) was Fludarabine, Busulfan, Melphalan and
anti-thymocyte globulin (ATG) (patients 3, 5, 6, 7, 8, 10,
11, 12 and 13); followed by Cyclophosphamide, Busulfan
and ATG (n = 6, 32 %; patients 14, 15, 16, 17, 18 and
19). Patients 1 and 9 were re-transplanted after graft fail-
ure. In these cases the age at the time of the second
transplantation was used for further analysis. Twelve pa-
tients presented with full donor chimerism (≥94 % donor
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cells), while four patients had mixed chimerism with
16.7 to 59.3 % of donor alleles between 2.3 and 4.6 years
post HSCT. In patient 19, chimerism was not part of the
standard diagnostic routine at the time of transplant-
ation, but enzyme activity analyses were always within
the normal range. Patient 15 developed a graft failure
within the first year after transplantation. As the family
decided not to carry out a second transplantation, he
was treated with ERT. Patient 14 presented with a slow
decline in donor chimerism over 10.9 years of follow-up
and was not re-transplanted or treated with ERT. Ten
patients developed acute Graft-versus-Host-Disease
(aGvHD) following transplantation. Patient 5 developed
chronic hepatopathy of unknown origin. GvHD of the
liver was excluded by liver biopsy.
Clinical review
Orthopedic clinical evaluations were available for all
patients and were carried out between an average age
of 2.1 years (range 0.7–4.5) at the first evaluation and
8.2 years (range 2.7–23.8) at the last evaluation. Re-
peated examinations were available in 18 patients
with an average follow-up period of 6.2 years (range
1.4–21.5).
All patients had limited shoulder abduction at some
point during follow-up, generally combined with
flexion contractures in other joints. The majority of
successfully transplanted patients showed a steady
state or even improvements in joint range of motion
(JROM) following HSCT (Fig. 1). At the most recent
follow-up there was no extension deficit found in the
knees, 69 % (11/16), hips, 53 % (8/15) and elbows,
44 % (7/16), of the patients. However, in 31 % (5/16)
of patients shoulder mobility worsened, leading to se-
vere restrictions. The two patients with graft failure
(patients 14 and 15) experienced progressive contrac-
tures in almost all joints. The improvement/worsening
was symmetrical in all cases. Detailed results of the
physical examinations of JROM over time are shown
in Table 2.
Thoracolumbar kyphosis was clinically diagnosed in
89 % (17/19) of patients at a mean age of 1.3 years and
was the first orthopedic symptom of the disease in most
cases. In 58 % (11/19) a combination of kyphosis and
scoliosis was found. Onset of kyphosis was observed
2.4 years earlier than the onset of scoliosis (mean age
3.7 years). Pectus excavatum was found in nine patients
(mean age 3.5 years) and did not significantly progress
during the follow-up period.






















1 f 2010 2.0 0.7 2.7 99.9 c.1205G > A p.W402X c.1205G > A p.W402X
2 f 2010 1.5 2.0 3.5 94 c.606c > A p.Y202X c.979G > C p.A327P
3 f 2009 1.3 1.9 3.2 100 n.a n.a. n.a. n.a.
4 f 2009 2.2 2.3 4.5 16.7 c.208C > T p.Q70X c.1205G > A p.W402X
5 m 2008 1.8 4.2 6.0 99.9 c.979G > C p.A327P c.1099G > C p.A367P
6 m 2008 1.5 3.2 4.7 98 c.208C > T p.Q70X c.175delA (fs132X) -
7 f 2008 2.0 2.0 4.0 99.9 c.208C > T p.Q70X c.208C > T p.Q70X
8 m 2008 1.5 4.6 6.0 59.3 c.208C > T p.Q70X c.208C > T p.Q70X
9 m 2008 2.2 4.2 6.4 100 c.208C > T p.Q70X c.1045_1047delGAC p.D349del
10 f 2007 1.2 5.7 6.9 99.9 c.208C > T p.Q70X c.1413C > G p.Y471X
11 f 2007 1.6 5.0 6.6 99.9 c.1205G > A p.W402X c.1205G > A p.W402X
12 f 2006 1.9 2.7 4.6 99.9 c.917G > A p.W306X c.1727 + 5G > A n.i.
13 m 2005 1.5 7.8 9.3 99.9 c.208C > T p.Q70X c.1205G > A p.W402X
14 m 2002 1.1 10.9 12.0 5.4 c.1205G > A p.W402X c.1205G > A p.W402X
15a m 2002 1.1 10.3 11.4 0 c.1205G > A p.W402X c.1205G > A p.W402X
16 f 2002 1.8 10.6 12.4 99.9 c.979G > C p.A327P n.i. n.i.
17 m 1999 1.8 13.3 15.2 50.5 c.208C > T p.Q70X c.979G > C p.A327P
18 f 1996 2.1 7.9 10.0 30 n.d. n.d. n.d. n.d.
19 m 1990 1.2 22.5 23.8 n.d. c.1205G > A p.W402X c.1205G > A p.W402X
m male, f female, y years, n.a not available, n.i. not identified, n.d not done
aPatient was treated with ERT after graft failure
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Limitations in hand function, such as fist clenching
and flexion deformities especially in distal interphalan-
geal joints (DIJ) and ulnar deviation, were common fea-
tures. The prevalence of carpal tunnel syndrome (CTS)
was 71 % (12/17). In two patients there was no data on
nerve conduction velocity available. Eleven patients
underwent bilateral open carpal tunnel release between
1.6 and 9.4 years of age. Only patient 16 required a revi-
sion three years after the initial surgery.
Genua valga were found in 89 % (17/19) of patients
and were first identified at a mean age of 3.2 years. Pro-
gression was noted in all cases. Five patients (patients 4,
7, 12, 16 and 17) underwent correction with eight-plates
between 3.4 and 11.1 years of age. Patient 17 required a
second surgery after recurrence of the deformity. Patient
19 was treated with three osteotomies at 8, 11 and
13 years of age. Pes planovalgus appeared to be the most
common foot deformity (16/19). The overall prevalence
of orthopedic manifestations are summarized in Fig. 2.
Imaging review
Cervical spine
MRI scans of the craniocervical junction (CCJ) were
available in 17 patients and were carried out between an
average age of 2.5 years (range 0.8–15.3) at the first
evaluation and 8.7 years (range 3.4–23.8) at the most re-
cent follow-up.
In the initial MRI the smallest CCJ diameters ranged
from 9 to 11 mm in 10 patients, while 6 patients pre-
sented with a diameter below 9 mm (patients 5, 6, 12,
14, 15 and 17) which was associated with reduced cere-
brospinal fluid (CSF) spaces around the cervical spinal
cord. Nevertheless, there were no signs of myelopathy.
By contrast, patient 1 presented with severe spinal cord
compression (CCJ diameter 3 mm) and floppy paraplegia
at 9.6 months of age and underwent surgical decompres-
sion twice.
Serial MRI scans were available for 15 patients. In
20 % (3/15) of patients the CCJ diameter improved
slightly (between 1 and 3 mm) over an average follow-
up period of 2.3 years (range 1.8–2.8). In 46 % (7/15)
stable diameters between 7–11 mm were measured at an
average follow-up period of 5.5 years (range 2.1–10.9).
In four patients (patients 10, 14, 15 and 17) craniocervi-
cal stenosis (CCS) was progressive. Images of patient 14
and 17 did not reveal signs of myelopathy during follow-
up. Patient 10 and 15 developed symptomatic CCS (CCJ
diameter 6 mm) at 6.9 and 4.9 years respectively and
were treated with surgical decompression. Patient 19
also underwent cervical decompression at 12.0 years of
age for symptomatic CCS; a pre-operative MRI was not
available for review. Assessments of CCJ diameters over
time are shown in Fig. 3.
Odontoid hypoplasia, as defined above, was observed
in 65 % (11/17) of the patients in the initial MRI study.
Four patients (patients 4, 8, 12 and 16) showed an im-
provement of the odontoid morphology, while in three
patients (patients 5, 13 and 17) the odontoid remained
unchanged. Patient 14, who experienced graft failure,
showed progressive odontoid hypoplasia. Patient 15,
who also developed graft failure, had an odontoid/body
ratio of 1.3 and developed atlanto-axial instability with
indication for surgical C1-2 fusion at the age of 4.9 years.
After surgery and the initiation of ERT, odontoid hypo-
plasia improved. In two patients (patients 1 and 9) only
one MRI scan was available. In contrast to all other pa-
tients, patient 19 presented with a proportionally smaller































Fig. 1 Course of joint mobility in successfully transplanted MPS I patients (n = 17). Change in grade of severity (assessed in categories as mild,
moderate severe) of shoulder abduction as well as elbow, hips and knee extension at the last available follow up is presented. The highest
percentage of improvement was seen in knees (63 % of patients), hips (40 % of patients) and elbows (38 % of patients)
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Table 2 Restriction of joint range of motion
No. Age at evaluation (y) Follow-up after HSCT (y) Shoulders Elbows Hips Knees
1 0.7 0 mild mild moderate severe
2.7 0.7 severe none mild moderate
2 1.1 0 severe none mild none
2.5 1.0 severe mild mild mild
3.5 2.0 severe mild n.d. n.d.
3 3.2 1.9 severe mild none mild
4 1.9 0 moderate mild none mild
2.1 0.2 moderate none none none
4.1 1.8 mild none none none
4.5 2.3 severe none none none
5 1.5 0 severe none mild none
3.9 2.1 severe mild mild mild
5.1 3.3 n.d. mild n.d. mild
6.0 4.2 severe mild none none
6 1.3 0 none none none none
3.5 2.0 mild none none none
4.7 3.2 mild none n.d. none
7 1.9 0 severe mild moderate none
3.0 1.0 mild moderate moderate mild
4.0 2.0 mild none mild none
8 1.2 0.3 none none moderate none
4.0 2.5 mild mild moderate mild
5.1 3.6 mild mild n.d. mild
6.0 4.6 moderate none none none
9 3.0 0.8 none none none none
3.9 1.7 mild none mild none
6.4 4.2 none mild mild none
10 2.2 1.0 moderate mild none mild
3.4 2.1 moderate mild mild mild
6.0 4.7 moderate mild none none
11 2.6 1.0 none none none none
5.1 3.5 mild mild none mild
6.6 5.0 severe mild none mild
12 1.8 0 severe moderate none none
4.0 2.1 moderate moderate severe mild
4.6 2.7 moderate mild moderate mild
13 1.0 0 severe none none none
2.5 1.0 n.d. none none mild
9.3 7.8 moderate none none none
14 1.7 0.7 moderate mild none mild
9.6 8.5 severe mild moderate mild
10.4 9.4 severe severe severe mild
12.0 10.9 severe severe severe severe
15 1.7 0.6 severe moderate mild mild
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resulting in a ratio >2. This patient was surgically treated
with C1-2 fusion due to atlanto-axial instability at
12.0 years of age. Unfortunately, pre-operative MRI
scans were not available for review. A normal odontoid
process was observed in five cases (patients 2, 6, 7, 10
and 11). All patients presented with increased soft tissue
mass surrounding the odontoid.
Thoracolumbar spine
Lateral radiographs of the thoracolumbar spine in stand-
ing position were available for 17 patients. In thirteen
patients with an average age of 2.6 years (range 0.8–7.8)
at the first evaluation, thoracolumbar kyphosis ranged
from 10° to 90°. While in four patients (patients 1, 2, 7,
and 8), thoracolumbar kyphosis was absent at an average
age of 1.6 years (range 1.1–2.0). Nine of ten patients
with an available follow-up showed progression of ky-
phosis of 8° to 57° over an average follow-up period of
4.8 years (1.1–12.8). In patient 14 the kyphotic angle
remained unchanged. In patient 15, who developed graft
failure, the first available radiograph at the age of
7.8 years revealed a kyphosis with a Cobb angle of 90°.
This patient subsequently underwent dorsal spondylod-
esis. Patient 19 was treated with dorsal spondylodesis
due to symptomatic kyphosis at 14.3 years of age. Pre-
operative x-rays were not available for review.
Anterior-posterior spinal x-rays in standing position
were available for 16 patients. Mild scoliosis was
found in eleven patients with a deformity ranging be-
tween 7° and 35°. Only patient 14, who had graft failure,
presented with moderate scoliosis (Cobb angle 40°). Overall,
eight patients were treated with braces due to kyphosis
and/or scoliosis. Patient 16 developed segmental instabil-
ity between L2 and L3 despite bracing at 10.8 years of age.
Surgical intervention is indicated but has not as yet been
performed. Longitudinal measurements of kyphotic and
scoliotic angles are shown in Table 3.
Hips
Radiographs of the hips were available in 16 patients
with an average age of 4.3 years (range 0.7–11.2) at the
first evaluation. Acetabular dysplasia was demonstrated
in all cases except one (patient 1). Due to hip contrac-
tures the acetabular index (AI) could not be assessed in
two patients (patients 8 and 14). In 13 of 14 patients
who could be analyzed (93 %) acetabular dysplasia (AI ≥
2 SD) was found in both hips. In patient 1 hip dysplasia
was absent at 0.7 years of age. Follow-up x-rays were
available for five patients and showed progressive hip
dysplasia over a follow-up period of 3.2 years (range
0.3–7.6). Twelve of the 16 patients (75 %) developed bi-
lateral femoral head subluxation (average MI left hip
Table 2 Restriction of joint range of motion (Continued)
7.0 5.9 severe severe severe mild
10.7 9.6 severe severe severe mild
11.4 10.3 moderate moderate severe mild
16 1.5 0 mild mild none mild
6.9 5.1 mild mild none none
11.8 9.9 mild mild none none
12.4 10.6 mild mild none none
17 3.9 2.1 mild mild none mild
8.1 6.3 mild mild n.d. mild
12.9 11.0 mild mild mild none
15.2 13.3 mild mild moderate none
18 2.7 0.6 n.d. mild n.d. mild
7.2 5.1 mild mild mild mild
8.8 6.7 severe mild n.d. mild
19 2.3 1.0 n.d. mild n.d. mild
7.2 6.0 n.d. mild severe mild
11.4 10.2 mild none nonea none
19.8 18.6 mild none nonea none
23.8 22.5 mild none milda none
Shoulder abduction was classified as mild (deficit ≤40°), moderate (deficit of 50–80°) or severe (deficit ≥90°)
Flexion joint contractures of elbows, hips and knees were classified as mild (5–15°), moderate (≥15°) or severe (≥25°)
y year, n.d.not done
aStatus after hip release surgery
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62.5 % ± 15.4; right hip 59.3 % ± 15.9). Patient 14, who
developed graft failure, presented with bilateral femoral
head dislocation (MI both hips 100 %). Three patients
(patients 1, 4 and 12) presented with normal head mi-
gration indices. Hip containment surgery was carried
out in four cases (patients 4, 10, 17 and 19) at a median
age of 6.3 years (range 3.9–11.4). Three patients under-
went Pemberton acetabuloplasty, while in one patient
Dega acetabuloplasty was performed.
Further signs of dysostosis multiplex
The presence of dysostosis multiplex was assessed by
examination of x-rays of the spine, thorax, pelvis
and hands (Additional file 1: Figure S1). Flattened
and beaked vertebrae, as well as paddle shaped ribs,
were found in all patients (19/19). Broad iliac wings
were observed in all patients with available x-rays of
the hips (16/16). All patients with available hand x-
rays (11/11) presented with typical manifestations of
dysostosis multiplex of the hands, such as hypoplas-
tic and irregular carpal bones (11/11), proximal
pointing of metacarpals (10/11), shortened phalanges
and metacarpals (9/11), as well as a V-shaped hypo-
plastic distal ulna and radius (9/11). Reduced calcifi-
cation of the bones of the hand was noted in all
cases (11/11).
Fig. 3 Longitudinal MRI assessments of CCJ diameters. The shortest anterior-to-posterior diameters of the CCJ (vertebrae C1-C3) were assessed on
sagittal T2-weighted MRI scans and are shown for each patient separately. The two patients with graft failure (patient 14 and 15) are presented as
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Fig. 2 Overall prevalence of orthopedic manifestations at any time point over the course of disease
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Table 3 Measurements of kyphosis and scoliosis
No. Age at evaluation (y) Follow-up after HSCT (y) Kyphotic angle (°) Scoliotic angle (°) Therapy
1 1.7 0 0 23 none
2 1.1 0 0 0 none
3.4 1.9 n.d. 0
3 1.2 0 30 n.d. Brace
2.2 0.9 38 n.d.
4 2.1 0 12 35 none
5 1.5 0 14 0 none
3.8 2.0 33 0
6 0.8 8 37 n.d. Brace
7 2.0 0 0 0 none
8 1.4 0 0 0
2.5 1.0 45 n.d. Brace
3.6 2.1 52 0
5.9 4.5 57 7
9 4.3 2.0 10 28 Brace
5.1 2.9 14 24
5.7 3.5 20 19
10 2.2 1.0 n.d. 0 none
3.3 2.1 n.d. 0
4.4 3.2 n.d. 0
11 1.3 0 30 0 none
3.7 2.1 n.d. 0
12 1.4 0 28 8 none
4.6 2.7 62 16
13a 1.5 0 45 9 none
2.5 1.0 45 9
8.1 6.6 73 10
14 0.9 2.4 30 n.d. Brace
9.6 8.6 32 40
15 7.8 6.8 90 n.d. Dorsal spondylodesis at 7.8 y
16 4.2 2.4 17 9
5.2 3.4 27 n.d.
6.4 4.5 32 15
6.9 5.1 40 n.d. Brace
10.8 8.9 n.d. 22
17 1.0 0 30 n.d.
4.5 2.7 40 n.d.
6.5 4.7 58 n.d. Brace
12.5 10.7 56 19
13.8 12.0 55 15
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Discussion
The present study gives a systematic overview of the
prevalence, progression and treatment of orthopedic
manifestations in 19 patients with Hurler syndrome after
HSCT. Due to the improved prognosis and survival rate
there is an increasing need for more detailed analysis of
the skeletal system involvement in such patients, in
order to develop more effective treatment strategies.
In Hurler syndrome, restriction in the joint range of
motion (JROM) of upper and lower limbs can be
observed early in life and may lead to severe disability
[1, 2, 5]. Deposition of GAGs and inflammatory
processes are thought to be responsible for joint disease
[7, 9, 32, 33]. In the present study joint stiffness in el-
bows, hips and knees did not progress or even improved
in some of the transplanted Hurler patients. The highest
percentage of improvement was seen in the knees (63 %
of patients) followed by hips (40 % of patients) and elbows
(38 % of patients). In prior studies the positive effects of
HSCT on joint mobility were documented in elbows,
knees and also shoulders of MPS I patients [22–25]. How-
ever, in our patient population shoulder abduction was
impaired in all patients and showed the highest rate of
progression (31 %) over time. Seven patients in our cohort
presented with severe restrictions of shoulder mobility
from the first available evaluation and only two of those
(25 %; patients 7 and 12) showed any improvement over
time. This is in contrast to previously published data by
Weisstein et al. 2004 [25] and Souillet et al. [23] who ob-
served improvement of shoulder mobility in 71 % (5/7)
and 85 % of patients, respectively. Irreversible shoulder
joint pathology prior to transplantation as a result of in-
flammation of the capsule [34, 35], could explain our re-
sults, however, the discrepancy with previous results
cannot be explained.
Our study identified carpal tunnel syndrome (CTS) in
12 patients (71 %). CTS is a common symptom of MPS
I, caused by bone dysplasia, a thickening of the flexor
retinaculum and GAG deposition within the carpal tun-
nel [16, 20]. Eleven patients, who were treated with open
carpal tunnel release and tenosynovectomy at the Uni-
versity Medical Center Hamburg-Eppendorf achieved
functional improvement of hand dexterity and remained
stable during a follow-up period of 1.6 to 6.1 years. Pa-
tient 16 needed revision three years later but was stable
during a follow up of four years. CTS relapse did not ap-
pear to be a common complication in this patient group.
Although there are no standards for the diagnosis and
treatment of CTS in MPS patients, a surgical release is
recommended in MPS patients. However, there is no
consensus about the optimal time for this surgery and a
lack of long-term outcome data [19, 20]. Khanna et al.
[18] suggested that early HSCT may decrease the risk of
CTS. However, in our study population no correlation
between the incidence of CTS and the age at transplant-
ation could be identified.
Hip dysplasia was found in all but one patient, who
was 8 months old at the time of evaluation. Progression
was found in all cases with available follow-up data. Hip
containment surgery was offered to four patients after a
careful clinical evaluation. Diagnostic assessments of soft
tissue and cartilaginous coverage of the hips by MRI and
arthrograms as well as general health, clinical symptoms,
rate of disease progression and individual risk for sur-
gery and anesthesia were taken into account. The preva-
lence of hip dysplasia is in accordance with findings in
the literature [6, 26, 36]. However, there is no agreement
on the indication for surgical treatment in these patients
[36] and efforts to reach an international consensus have
been made, but have so far not been reached due to a
lack of evidence [36, 37].
The majority of patients (89 %) presented with pro-
gressive genua valga. Epiphyseodesis by eight-plate im-
plantation was a reliable and safe method to correct the
deformity. Overcorrection might be indicated, as recur-
rences are common [38, 39].
In the present study almost 90 % of patients presented
with early onset and progressive thoracolumbar kyphosis
(mean age 1.3 years). However, only two patients (pa-
tients 15 and 19) needed surgical intervention at 7.8 and
14.3 years of age, respectively. Muscle hypotonia and
underdeveloped paraspinal muscles as well as ossifica-
tion abnormalities of the vertebral bodies are assumed
to be responsible for the development of kyphosis in
MPS diseases [6, 26, 40]. Stoop et al. [41] described early
onset of thoracolumbar kyphosis and significant progres-
sion despite HSCT. Abelin and colleagues [42] found se-
vere progressive thoracolumbar gibbus in 16 out of 72
MPS I patients, which led to surgical treatment in 14 pa-
tients. Therefore, kyphosis should be carefully monitored
Table 3 Measurements of kyphosis and scoliosis (Continued)
18 6.2 4.1 60 n.d.
8.8 6.7 80 16
10.0 7.9 72 n.d. Brace
19b 13.5 12.3 n.a.b 7 Dorsal spondylodesis at 14.3 y
y year, n.d.not done, n.a not available
aNo continuous follow-up was performed as patient lived abroad. Bracing treatment planned
bPre-operative x-rays not available for review
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in transplanted MPS I patients in order to avoid spinal
cord compression.
Eleven patients presented with odontoid hypoplasia in
the first available MRI, and 36 % (4/11) improved during
an average follow-up of 5.2 years (2.3–10.6) after trans-
plantation. By contrast, the appearance of the dens did
not change on follow-up in both patients with graft fail-
ure (patients 14 and 15). However, patient 15 showed
significant improvement of dens hypoplasia three years
after atlanto-axial stabilization and initiation of ERT,
suggesting that the improvement might be related to
ERT. The prevalence of odontoid hypoplasia is in align-
ment with the findings of previous studies [14, 15, 41].
Cervical spinal cord compression is one of the most
feared complications in Hurler syndrome. Studies on
CCS have been carried out in MPS I, IVA and VI pa-
tients [26, 28, 43]. No documentation of CCS progres-
sion in Hurler patients have been published to date. The
majority of patients in this study (81 %) presented with
asymptomatic stenosis of the CCJ, which stabilized or
even improved during follow-up after HSCT. An
anterior-to-posterior spinal canal parameter of less than
12 mm is assumed to be associated with clinical symp-
toms of cord compression [28]. In our study myelopathy,
as assessed by MRI and/or somatosensory evoked poten-
tial (SEP), was not observed in patients with spinal canal
diameters between 9–12 mm. Furthermore, even in
some patients with diameters between 6–9 mm and im-
paired CSF signal, no signs of cord compression were
found. On the other hand, patients 10 and 15, with a
spinal canal diameter of 6 mm, developed neurological
symptoms and signs of myelopathy and required decom-
pression surgery. CCJ measurements are highly
dependent on the MRI sequences used (slice thickness,
tissue contrast, orientation) and therefore might not be
comparable between different centers. The spinal canal
diameters should only serve as one of several tools
(along with clinical neurological examination, SEP and
sleep laboratory evaluation) for assessing the need for a
surgical intervention.
A limitation of this study is the retrospective design
and the use of different transplantation regimes. How-
ever, there was no correlation between the type of condi-
tioning regime or the type of donor and the clinical
manifestation of musculoskeletal symptoms. Due to the
small sample size, and the different variables assessed at
different ages and follow-up time points, statistical inter-
pretability of the data is limited. Overall we were not
able to identify any obvious correlation between the dif-
ferent parameters that might influence the clinical out-
come. There was no significant difference in the
incidence or severity of orthopedic manifestations in pa-
tients after early HSCT (≤18 months of age) or late
HSCT (>18 months). Physical examinations of the
JROM are subjective assessments and therefore classifi-
cation of the severity of joint restrictions may vary
among physicians. Assessment of AI and MI in hip im-
aging is dependent on correct positioning and may be
inaccurate due to hip contractures. No MRI-based norm
values for odontoid lengths in children exist at present.
CT studies revealed ossification of the odontoid might
be incomplete up to the age of 8–14 years [44]. There-
fore a delay of ossification in MRI studies might be mis-
interpreted as odontoid hypoplasia. Although CT is the
technique of choice to estimate the ossification rate of
the CCJ it is ethically not justifiable in pediatric patients
due to high radiation exposure.
Conclusion
In conclusion, successful HSCT can benefit some mus-
culoskeletal manifestations in Hurler syndrome, as
stabilization or even improvement in the joint mobility
of elbows, hips and knees was found in the majority of
transplanted Hurler patients. However, shoulder abduc-
tion was restricted in ¾ of patients and progressive in
31 %. Partial correction of odontoid hypoplasia, as well
as prevention of progressive craniocervical stenosis, fol-
lowing HSCT has an important impact on the overall
clinical outcome. Nevertheless, thoracolumbar kyphosis,
scoliosis, hip dysplasia and genua valga are progressive
despite HSCT and may require conservative orthopedic
or surgical intervention. Furthermore, the overall burden
of orthopedic disease is significant. Walking distance
was impaired in almost all of the patients and the major-
ity was not able to perform a 6-minute-walk-test
(6MWT) due to muscle weakness and/or pain. At the
last follow up, 47 % of patients were partially wheelchair
dependent, 10 % wheelchair bound and 25 % of patients
regularly experienced pain in the spine, hips and lower
extremities due to orthopedic problems. Surgical treat-
ment for orthopedic complications was needed in almost
60 % of patients. A multi-disciplinary team including
metabolic specialists, pediatric orthopedists, orthopedic
surgeons, neurosurgeons and physiotherapists is essen-
tial to prevent musculoskeletal complications. New
therapeutic strategies based around the use of anti-
inflammatory drugs (e.g. anti-TNF-alpha antibodies,
pentosan polysulfate) for the treatment of joint disease
may be promising approaches [10, 33, 45].
Additional file
Additional file 1: Figure S1. (a-d): Radiographs of dysostosis multiplex.
(a) Anterior-posterior spine x-ray of patient 14 at 9.6 years of age: scoliosis
(40°) and paddle shaped ribs. (b) Lateral spine x-ray of patient 12 at
4.6 years of age: thoracolumbar gibbus (62°), flattened and beaked
vertebrae. (c) X-ray of the left hand of patient 14 at 7.8 years of age:
hypoplastic and irregular carpal bones, proximal pointing of metacarpals,
shortened phalanges and metacarpals and V-shaped hypoplastic distal
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ulna and radius, decalcification of the bones of the hand. (d) Anterior-
posterior x-ray of patient 4 at 3.4 years of age: broad iliac wings, hip
dysplasia. (PNG 804 kb)
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